Don't Just Read the News, Understand It.
Published loading...Updated

Living drugs that reprogram patients’ immune cells show early promise against hard-to-treat brain tumors

  • T-Cells were genetically modified in a lab to recognize specific proteins on brain tumor cells.
  • CAR-T cells were modified to reprogram suppressor T-cells into killer T-cells to fight the tumor.
  • The modifications made T-cells more effective in battling cancer by outsmarting its ability to hide from detection.
Insights by Ground AI
Does this summary seem wrong?

14 Articles

All
Left
6
Center
5
Right
2
Lean Right

At the Maggiore Hospital in Cremona, the first surgery in Europe for the removal of a brain tumor was performed, using two revolutionary techniques

·Italy
Read Full Article
Associated Press NewsAssociated Press News
+8 Reposted by 8 other sources
Lean Left

A new strategy to attack aggressive brain cancer shrank tumors in two early tests - Seymour Tribune

WASHINGTON (AP) — A new strategy to fight an extremely aggressive type of brain tumor showed promise in a pair of experiments with a handful of patients. Scientists took patients’ own immune cells and turned them into “living drugs” able to recognize and attack glioblastoma. In the first-step tests, those cells shrank tumors at least […]

·United States
Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 46% of the sources lean Left
46% Left
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Winnipeg Free Press broke the news in Winnipeg, Canada on Wednesday, March 13, 2024.
Sources are mostly out of (0)

You have read 1 out of your 5 free daily articles.

Join millions of well-informed readers who use Ground to compare coverage, check their news blindspots, and challenge their worldview.